Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

Correlating Quantitative Fecal Immunochemical Test Results with Neoplastic Findings on Colonoscopy in a Population-Based Colorectal Cancer Screening Program: A Prospective Study.

Shahidi N, Gentile L, Gondara L, Hamm J, McGahan CE, Enns R, Telford J.

Can J Gastroenterol Hepatol. 2016;2016:4650471. doi: 10.1155/2016/4650471.

2.

Colorectal cancer mortality 10 years after a single round of guaiac faecal occult blood test (gFOBT) screening: experiences from a Danish screening cohort.

Bjerrum A, Andersen O, Fischer A, Lindebjerg J, Lynge E.

BMJ Open Gastroenterol. 2016 Dec 7;3(1):e000120. doi: 10.1136/bmjgast-2016-000120.

3.

Comparison of One versus Two Fecal Immunochemical Tests in the Detection of Colorectal Neoplasia in a Population-Based Colorectal Cancer Screening Program.

Moosavi S, Enns R, Gentile L, Gondara L, McGahan C, Telford J.

Can J Gastroenterol Hepatol. 2016;2016:5914048. doi: 10.1155/2016/5914048.

4.

Colorectal cancer screening: Opportunities to improve uptake, outcomes, and disparities.

Shahidi N, Cheung WY.

World J Gastrointest Endosc. 2016 Dec 16;8(20):733-740. doi: 10.4253/wjge.v8.i20.733. Review.

5.

Performance of a quantitative fecal immunochemical test in a colorectal cancer screening pilot program: a prospective cohort study.

Telford J, Gentile L, Gondara L, McGahan C, Coldman A.

CMAJ Open. 2016 Nov 4;4(4):E668-E673. doi: 10.9778/cmajo.20160047.

6.

Adherence to colorectal cancer screening: four rounds of faecal immunochemical test-based screening.

van der Vlugt M, Grobbee EJ, Bossuyt PM, Bongers E, Spijker W, Kuipers EJ, Lansdorp-Vogelaar I, Essink-Bot ML, Spaander MC, Dekker E.

Br J Cancer. 2017 Jan 3;116(1):44-49. doi: 10.1038/bjc.2016.399.

PMID:
27923037
7.

Are Hemorrhoids Associated with False-Positive Fecal Immunochemical Test Results?

Kim NH, Park JH, Park DI, Sohn CI, Choi K, Jung YS.

Yonsei Med J. 2017 Jan;58(1):150-157. doi: 10.3349/ymj.2017.58.1.150.

8.

Resilience of a FIT screening programme against screening fatigue: a modelling study.

Greuter MJ, Berkhof J, Canfell K, Lew JB, Dekker E, Coupé VM.

BMC Public Health. 2016 Sep 22;16(1):1009.

9.

Protocol Outlines for Parts 1 and 2 of the Prospective Endoscopy III Study for the Early Detection of Colorectal Cancer: Validation of a Concept Based on Blood Biomarkers.

Rasmussen L, Wilhelmsen M, Christensen IJ, Andersen J, Jørgensen LN, Rasmussen M, Hendel JW, Madsen MR, Vilandt J, Hillig T, Klærke M, Münster AM, Andersen LM, Andersen B, Hornung N, Erlandsen EJ, Khalid A, Nielsen HJ.

JMIR Res Protoc. 2016 Sep 13;5(3):e182. doi: 10.2196/resprot.6346.

10.
11.

Colorectal Cancer Screening in Average Risk Populations: Evidence Summary.

Tinmouth J, Vella ET, Baxter NN, Dubé C, Gould M, Hey A, Ismaila N, McCurdy BR, Paszat L.

Can J Gastroenterol Hepatol. 2016;2016:2878149. doi: 10.1155/2016/2878149. Review.

12.

Academic hospital staff compliance with a fecal immunochemical test-based colorectal cancer screening program.

Vlachonikolou G, Gkolfakis P, Sioulas AD, Papanikolaou IS, Melissaratou A, Moustafa GA, Xanthopoulou E, Tsilimidos G, Tsironi I, Filippidis P, Malli C, Dimitriadis GD, Triantafyllou K.

World J Gastrointest Oncol. 2016 Aug 15;8(8):629-34. doi: 10.4251/wjgo.v8.i8.629.

13.

The effectiveness of FOBT vs. FIT: A meta-analysis on colorectal cancer screening test.

Mousavinezhad M, Majdzadeh R, Akbari Sari A, Delavari A, Mohtasham F.

Med J Islam Repub Iran. 2016 May 9;30:366.

14.

Implementation of immunochemical faecal occult blood test in general practice: a study protocol using a cluster-randomised stepped-wedge design.

Juul JS, Bro F, Hornung N, Andersen BS, Laurberg S, Olesen F, Vedsted P.

BMC Cancer. 2016 Jul 11;16:445. doi: 10.1186/s12885-016-2477-9.

15.

Human Blood Autoantibodies in the Detection of Colorectal Cancer.

Negm OH, Hamed MR, Schoen RE, Whelan RL, Steele RJ, Scholefield J, Dilnot EM, Shantha Kumara HM, Robertson JF, Sewell HF.

PLoS One. 2016 Jul 6;11(7):e0156971. doi: 10.1371/journal.pone.0156971.

16.

Performance of the Fecal Immunochemical Test for Colorectal Cancer Screening Using Different Stool-Collection Devices: Preliminary Results from a Randomized Controlled Trial.

Shin HY, Suh M, Baik HW, Choi KS, Park B, Jun JK, Hwang SH, Kim BC, Lee CW, Oh JH, Lee YK, Han DS, Lee DH.

Gut Liver. 2016 Nov 15;10(6):925-931. doi: 10.5009/gnl15479.

17.

The potential of imaging techniques as a screening tool for colorectal cancer: a cost-effectiveness analysis.

Greuter MJ, Berkhof J, Fijneman RJ, Demirel E, Lew JB, Meijer GA, Stoker J, Coupé VM.

Br J Radiol. 2016 Jul;89(1063):20150910. doi: 10.1259/bjr.20150910.

PMID:
27194458
18.

Colorectal cancer.

Kuipers EJ, Grady WM, Lieberman D, Seufferlein T, Sung JJ, Boelens PG, van de Velde CJ, Watanabe T.

Nat Rev Dis Primers. 2015 Nov 5;1:15065. doi: 10.1038/nrdp.2015.65. Review.

19.

Genetic Variants Associated with Colorectal Adenoma Susceptibility.

Abulí A, Castells A, Bujanda L, Lozano JJ, Bessa X, Hernández C, Álvarez-Urturi C, Pellisé M, Esteban-Jurado C, Hijona E, Burón A, Macià F, Grau J, Guayta R, Castellví-Bel S, Andreu M; PROCOLON research group..

PLoS One. 2016 Apr 14;11(4):e0153084. doi: 10.1371/journal.pone.0153084.

20.

Recommendations for a step-wise comparative approach to the evaluation of new screening tests for colorectal cancer.

Young GP, Senore C, Mandel JS, Allison JE, Atkin WS, Benamouzig R, Bossuyt PM, Silva MD, Guittet L, Halloran SP, Haug U, Hoff G, Itzkowitz SH, Leja M, Levin B, Meijer GA, O'Morain CA, Parry S, Rabeneck L, Rozen P, Saito H, Schoen RE, Seaman HE, Steele RJ, Sung JJ, Winawer SJ.

Cancer. 2016 Mar 15;122(6):826-39. doi: 10.1002/cncr.29865.

Items per page

Supplemental Content

Support Center